Style | Citing Format |
---|---|
MLA | Hoseinnejad A, et al.. "Insights Into the Structure, Function, and Impact of Candida Albicans Upc2 Gene on Azole Resistance; a Mini-Review." Current Medical Mycology, vol. 10, no. , 2024, pp. -. |
APA | Hoseinnejad A, Mahdizade AH, Erfaninejad M, Kermani F, Ghazanfari M, Arbabi A, Bahreiny SS, Bozorgomid A, Moradi M, Haghani I, Abastabar M (2024). Insights Into the Structure, Function, and Impact of Candida Albicans Upc2 Gene on Azole Resistance; a Mini-Review. Current Medical Mycology, 10(), -. |
Chicago | Hoseinnejad A, Mahdizade AH, Erfaninejad M, Kermani F, Ghazanfari M, Arbabi A, Bahreiny SS, et al.. "Insights Into the Structure, Function, and Impact of Candida Albicans Upc2 Gene on Azole Resistance; a Mini-Review." Current Medical Mycology 10, no. (2024): -. |
Harvard | Hoseinnejad A et al. (2024) 'Insights Into the Structure, Function, and Impact of Candida Albicans Upc2 Gene on Azole Resistance; a Mini-Review', Current Medical Mycology, 10(), pp. -. |
Vancouver | Hoseinnejad A, Mahdizade AH, Erfaninejad M, Kermani F, Ghazanfari M, Arbabi A, et al.. Insights Into the Structure, Function, and Impact of Candida Albicans Upc2 Gene on Azole Resistance; a Mini-Review. Current Medical Mycology. 2024;10():-. |
BibTex | @article{ author = {Hoseinnejad A and Mahdizade AH and Erfaninejad M and Kermani F and Ghazanfari M and Arbabi A and Bahreiny SS and Bozorgomid A and Moradi M and Haghani I and Abastabar M}, title = {Insights Into the Structure, Function, and Impact of Candida Albicans Upc2 Gene on Azole Resistance; a Mini-Review}, journal = {Current Medical Mycology}, volume = {10}, number = {}, pages = {-}, year = {2024} } |
RIS | TY - JOUR AU - Hoseinnejad A AU - Mahdizade AH AU - Erfaninejad M AU - Kermani F AU - Ghazanfari M AU - Arbabi A AU - Bahreiny SS AU - Bozorgomid A AU - Moradi M AU - Haghani I AU - Abastabar M TI - Insights Into the Structure, Function, and Impact of Candida Albicans Upc2 Gene on Azole Resistance; a Mini-Review JO - Current Medical Mycology VL - 10 IS - SP - EP - PY - 2024 ER - |